Picard Medical, Inc. (PMI)
NYSEAMERICAN: PMI · Real-Time Price · USD
8.70
+0.49 (5.97%)
Sep 26, 2025, 4:00 PM EDT - Market closed

Company Description

Picard Medical, Inc., through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.

The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.

The company operates in the USA, Europe, and internationally. The company was incorporated in 2021 and is based in Tucson, Arizona.

Picard Medical, Inc. is a subsidiary of Hunniwell Picard I, Llc.

Picard Medical, Inc.
Picard Medical logo
Country United States
Founded 1981
IPO Date Aug 29, 2025
Industry Medical Devices
Sector Healthcare
Employees 75
CEO Patrick Schnegelsberg

Contact Details

Address:
1992 E Silverlake Road
Tucson, Arizona 85713
United States
Phone 520 545 1234
Website syncardia.com

Stock Details

Ticker Symbol PMI
Exchange NYSEAMERICAN
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.00
CIK Code 0002030617
SIC Code 3841

Key Executives

Name Position
Patrick NJ Schnegelsberg Chief Executive Officer and Director
Bernard Skaggs Chief Financial Officer
Matt Schuster Chief Operating Officer
Richard Fang Director
Daniel Teo Director
Chris Hsieh Director
Richard G. Smith Scientific Advisor, SynCardia
Frank Tinker Chief Technology Officer, SynCardia

Latest SEC Filings

Date Type Title
Sep 18, 2025 PRE 14A Other preliminary proxy statements
Sep 12, 2025 10-Q Quarterly Report
Sep 10, 2025 8-K Current Report
Sep 4, 2025 8-K Current Report
Sep 2, 2025 424B4 Prospectus
Aug 28, 2025 CERT Certification by an exchange approving securities for listing
Aug 12, 2025 EFFECT Notice of Effectiveness
Aug 11, 2025 8-A12B Registration of securities
Aug 6, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Jul 30, 2025 FWP Free Writing Prospectus